Thermo Fisher Scientific Inc. (TMO) Shares Sold by Ascension Asset Management LLC  Anthony Miller | Aug 17th, 2018
Ascension Asset Management LLC lessened its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 16.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,555 shares of the medical research company's stock after selling 2,430 shares during the quarter. Thermo Fisher Scientific makes up approximately 2.4% of Ascension Asset Management LLC's holdings, making the stock its 8th biggest holding. Ascension Asset Management LLC's holdings in Thermo Fisher Scientific were worth $2,601,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the company. Princeton Portfolio Strategies Group LLC raised its stake in shares of Thermo Fisher Scientific by 1.6% in the 2nd quarter. Princeton Portfolio Strategies Group LLC now owns 35,920 shares of the medical research company's stock valued at $7,440,000 after purchasing an additional 581 shares in the last quarter. State Treasurer State of Michigan raised its stake in shares of Thermo Fisher Scientific by 1.3% in the 2nd quarter. State Treasurer State of Michigan now owns 449,531 shares of the medical research company's stock valued at $93,116,000 after purchasing an additional 5,900 shares in the last quarter. Flossbach Von Storch AG raised its stake in shares of Thermo Fisher Scientific by 2.4% in the 2nd quarter. Flossbach Von Storch AG now owns 37,010 shares of the medical research company's stock valued at $7,666,000 after purchasing an additional 850 shares in the last quarter. CIBC World Markets Inc. raised its stake in shares of Thermo Fisher Scientific by 84.1% in the 2nd quarter. CIBC World Markets Inc. now owns 16,666 shares of the medical research company's stock valued at $3,452,000 after purchasing an additional 7,615 shares in the last quarter. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in shares of Thermo Fisher Scientific by 2.6% in the 2nd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 200,825 shares of the medical research company's stock valued at $41,599,000 after purchasing an additional 5,037 shares in the last quarter. Institutional investors and hedge funds own 85.69% of the company's stock. Get Thermo Fisher Scientific alerts:
In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of the company's stock in a transaction dated Monday, June 4th. The shares were sold at an average price of $212.00, for a total value of $530,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website . Also, CEO Marc N. Casper sold 50,000 shares of the company's stock in a transaction dated Monday, August 6th. The stock was sold at an average price of $233.95, for a total transaction of $11,697,500.00. Following the completion of the transaction, the chief executive officer now owns 320,122 shares of the company's stock, valued at approximately $74,892,541.90. The disclosure for this sale can be found here . In the last 90 days, insiders sold 168,050 shares of company stock valued at $37,585,029. 0.49% of the stock is owned by insiders.
TMO opened at $230.79 on Friday. The stock has a market cap of $93.22 billion, a P/E ratio of 24.32, a price-to-earnings-growth ratio of 1.69 and a beta of 1.13. Thermo Fisher Scientific Inc. has a fifty-two week low of $172.15 and a fifty-two week high of $236.29. The company has a current ratio of 1.58, a quick ratio of 1.11 and a debt-to-equity ratio of 0.67.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 25th. The medical research company reported $2.75 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.12. The firm had revenue of $6.08 billion for the quarter, compared to analyst estimates of $5.90 billion. Thermo Fisher Scientific had a net margin of 10.36% and a return on equity of 16.28%. Thermo Fisher Scientific's quarterly revenue was up 21.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.30 earnings per share. sell-side analysts predict that Thermo Fisher Scientific Inc. will post 10.98 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Shareholders of record on Monday, September 17th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Friday, September 14th. Thermo Fisher Scientific's dividend payout ratio (DPR) is 7.17%.
Several equities research analysts recently weighed in on TMO shares. Morgan Stanley increased their price objective on shares of Thermo Fisher Scientific from $233.00 to $242.00 and gave the stock an "overweight" rating in a research note on Thursday, July 26th. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a "buy" rating to a "hold" rating in a research note on Tuesday, August 7th. JPMorgan Chase & Co. reiterated an "overweight" rating and set a $300.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, July 26th. Finally, ValuEngine lowered shares of Thermo Fisher Scientific from a "buy" rating to a "hold" rating in a research note on Wednesday, June 20th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has an average rating of "Buy" and an average price target of $239.08.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
See Also: How Do You Make Money With Penny Stocks?
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO). Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter . Ã‚